Historical formula review. This article examines the AZOTH 2.0 version described in our archive. The preserved ingredient table and images are archival, not a verified current shopping or dosing guide. This review does not establish present prices, stock or equivalence between product versions.
Page Contents
A caffeine-free archive with sulbutiamine, theacrine and hordenine
The archived version 2.0 table individually listed ashwagandha, tyrosine and phosphatidylserine at 500 mg each, sulbutiamine 400 mg, alpha-GPC 300 mg, theacrine 100 mg, hordenine 50 mg, black pepper extract and huperzine A. The version number is essential to identifying the formula.
Formula assessment
Caffeine-free is not a complete account of this ingredient mix and should not be transformed into a universal stimulant-free or safety claim. “Triple strength” likewise requires a specified comparator and endpoint, neither established by the archived article. Large numbers and open disclosure make a label more inspectable; they do not show that every ingredient or the combination is effective.
Ingredient table retained from the original review
The table records the original article’s ingredient names and quantities. It is a historical transcription, not independent testing. Original daily-value percentages are omitted where transcribed because they can be outdated or inconsistent; percentage standardisations attached to ingredients are retained. It should not be used to calculate a dose or substitute for an authenticated label.
AZOTH 2.0 Ingredients | |
| Ingredients | Amount Per Serving |
| Ashwagandha Extract | 500 mg |
| L-Tyrosine | 500 mg |
| Phosphatidylserine | 500 mg |
| Sulbutiamine | 400 mg |
| Alpha-GPC | 300 mg |
| Theacrine (as TeaCrine®) | 100 mg |
| Hordenine HCl | 50 mg |
| BioPerine® | 10 mg |
| Huperzine A | 100 mcg |
Revised conclusion
The useful finding is the particular 2.0 formulation and its distinct non-caffeine compounds. This page does not establish a confidence treatment, a study aid for sleep deprivation or a safe cycling plan for sulbutiamine.
The former rating, price-based recommendation and unverified personal-experience claims have been removed. Ingredient studies, marketing mechanisms and a review of a label are different forms of information. None alone establishes how the complete product performs. Before assessing a later version, identify the exact manufacturer label, serving size, quantities and warnings; do not transfer old directions or conclusions between formulas.
Related reading
Ingredient evidence is discussed separately in Ashwagandha Review: Stress, Sleep, Extracts and Safety; Tyrosine Review; Phosphatidylserine Review.
